Charlotte A. Slade

This study uses single-cell multi-omics to compare immune cell landscapes and vaccine responses in SAD and CVID patients, identifying unique cellular and molecular features associated with poor vaccination responses.

This study shows that CLL cells rapidly adapt to venetoclax by upregulating pro-survival proteins and cytokines, suggesting combination therapies targeting these pathways could improve treatment outcomes.